Irritable bowel syndrome.
Questions from patients about analgesic pharmacotherapy and responses from the authors are presented to help educate patient sand make them more effective self-advocates. The topics addressed in this issue are the signs, symptoms, and treatment of irritable bowel syndrome (IBS). A discussion of pain management and complementary therapies is included.
Banerjee
Sanjoy
S
Department of Anesthesiology and Pain Medicine, University of California at Davis Medical Center, Sacramento, California 95817, USA. sanjoy.banerjee@ucdmc.ucdavis.edu
Colón
Yvette
Y
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D000529:Complementary Therapies; D005247:Feeding Behavior; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*; D008019:Life Style; D010353:Patient Education as Topic; D018373:Peripheral Nervous System Agents / Q000627:therapeutic use; D011613:Psychotherapy
D000929:Antidepressive Agents, Tricyclic; D018680:Cholinergic Antagonists; D005765:Gastrointestinal Agents; D018373:Peripheral Nervous System Agents